Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis
Aim: Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing pre–cancerous cervical lesions when given in a three–dose schedule. Some post–hoc trial data suggest that one dose prevents HPV infection. If one dose could prevent pre–cancerous cervical lesions, then global ce...
Main Authors: | Julia ML. Brotherton, Alison Budd, Christopher Rompotis, Natasha Bartlett, Michael J. Malloy, Rachael L. Andersen, Kim AR. Coulter, Peter W. Couvee, Nerida Steel, Gail H. Ward, Marion Saville |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Papillomavirus Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852119300588 |
Similar Items
-
Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
by: Julia M.L. Brotherton, et al.
Published: (2015-12-01) -
Addressing Human Papillomavirus Vaccination in Primary Care Pediatrics
by: Subramaniam, Natasha Marie
Published: (2019) -
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
by: Katherine E. Gallagher, et al.
Published: (2018-12-01) -
Are the VAERS-included reactions following the human papillomavirus immunization correlated to the number of vaccine doses?
by: Dimitri Poddighe
Published: (2020-01-01) -
Factors Associated with Human Papillomavirus Vaccination Among Diverse Adolescents in a Region with Low Human Papillomavirus Vaccination Rates
by: Deanna Kepka, et al.
Published: (2018-09-01)